Abstract Library

#4574 Long-acting somatostatin analogue injections for treating gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and acromegaly: BackSOM – A patient preference study

Introduction: Long-acting somatostatin analogues, lanreotide and octreotide, are indicated for first-line treatment of GEP-NETs and acromegaly. Lanreotide was approved in 2007 in Europe, and is supplied as a prefilled, ready-to-use syringe (LAN-PF). In 2021, a generic form of lanreotide was released and supplied in a syringe requiring assembly (LAN-RA). To ensure patient compliance with treatment, it is important to understand their injection experiences.

Conference:

Presenting Author: Hernando Cubero J

Authors: Rodien-Louw C, Simo-Servat A, Dubois M, Sheppard J, McDonnell M,

Keywords: gastroenteropancreatic neuroendocrine tumour, GEP-NET, acromegaly, lanreotide, LA-SSA, somatostatin, patient preference,

#4314 Understanding neuroendocrine cancer: A palliative care perspective in rural India

Introduction: Introduction: Neuroendocrine cancer (NEC) refers to rare tumours arising from cells that possess both neural and endocrine functions, affecting organs such as the pancreas, lungs, and gastrointestinal tract. In rural India, limited access to specialised oncology care results in delayed diagnoses and insufficient support for NEC patients, making holistic palliative care essential for these communities.

Conference:

Presenting Author:

Authors: Manna A,

Keywords: neuroendocrine cancer, palliative care, oncology social work, rural healthcare, psychosocial support, quality of life,

#3727 PREF-NET: A patient preference and experience study of lanreotide autogel (LAN) administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the UK

Introduction: The somatostatin analogue LAN is a common first-line treatment for NETs that can be given at home in a ready-to-use syringe every 4 weeks in the UK.

Conference:

Presenting Author: Khan M

Authors: Khan M, Davies L, Back M, Shah T, Pritchard D,

Keywords: patient participation, somatostatin analogues, injections, quality of life, value-based health care,

#3675 Care trajectory, informational needs and challenges of patients with neuroendocrine tumors – A mixed methods study

Introduction: Patients with neuroendocrine tumors (NET) encounter different challenges, including delayed diagnosis and difficulty finding NET-specific information of high-quality.

Conference:

Presenting Author:

Authors: Bénard F, Mercier F, Huez S, Pomey M,

Keywords: neuroendocrine, cancer, needs, information, challenges,

#3496 Children with Primary Hyperparathyroidism After Parathyroidectomy

Introduction: Surgical treatment is the radical and most effective treatment for primary hyperparathyroidism (PHP). According to a number of studies, it has been shown that parathyroidectomy leads to an improvement in the quality of life in patients.

Conference:

Presenting Author:

Authors: Rixsieva N, Ismailov S,

Keywords: primary hyperparathyroidism, parathyroidectomy, children, quality of life,